PRXL up +1.06% percent Today $PRXL High is at 55.19 and the Low 54.10 with current volume of 166,259.
Recent News posted below.
Parexel International Corp PRXL other info.
http://investorshangout.com/Parexel-Internati...RXL-55174/
PRXL Parexel International Corp Recent Headline News
Regulatory Affairs Outsourcing Market - Global Industry Analysis 2014 - 2020
M2 - Tue Nov 11, 9:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/8t6h79/regulatory) has announced the addition of the "Regulatory Affairs Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering. The global regulatory affairs outsourcing market is segmented by services into regulatory affairs; clinical trial applications and product registrations; regulatory writing and publishing; regulatory consulting and legal representation; and others (post approval maintenance, reimbursement consulting etc.). Regulatory writing and publishing services accounted for the largest share of more than 40% of the overall regulatory affairs outsourcing market in 2013 and is expected to maintain its lead during the forecast period through 2014 to 2020. Factors that have contributed towards the large market size of the regulatory writing and publishing services are increasing need for user/reviewer friendly and complete drug application submissions, and sound knowledge for drug development services. Additionally, a well-written clinical study report (CSR) can help in adding a lot of value in the final production of clinical trial documentation, thereby complying with stringent regulatory requirements of the drug development process. The regulatory consulting and legal representation services segment is also estimated to grow at an approximate CAGR of above 14%. The major driving factors for the rapid growth of this segment are growing demand of drug manufacturing companies for product safety and efficacy evaluations. Furthermore, the need of various pharmaceutical companies to minimize business impacts such as product recalls and loss of sales, and ensure global environmental compliance would also propel the growth of the regulatory consulting and legal representation services segment. Currently, the regulatory affairs outsourcing market is fragmented due to the involvement of several established and emerging contract research organizations. Some of the major players operating in the global regulatory affairs outsourcing market are Charles River Laboratories International, Inc., Covance Group Ltd., Parexel International Corporation, WuXi AppTec, Quintiles Transnational Holdings, Inc., Medpace, Inc., Promedica International, Clinilabs, Inc., Accell Clinical Research, LLC, Criterium, Inc., ICON plc and Pharmaceutical Product Development. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Regulatory Affairs Outsourcing Market Overview Chapter 4 Global Regulatory Affairs Outsourcing Market, by Services Chapter 5 Global Regulatory Affairs Outsourcing Market, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - Accell Clinical Research, LLC - Charles River Laboratories International, Inc. - Clinilabs, Inc. - Covance, Inc. - Criterium, Inc. - ICON plc - Medpace, Inc. - PAREXEL International Corporation - PRA International, Inc. - Pharmaceutical Product Development, LLC - Promedica International - Quintiles Transnational Corporation - WuXi AppTec For more information visit http://www.researchandmarkets.com/research/8t6h79/regulatory
PRXL: 54.92 (+0.42), CRL: 64.16 (+0.23), ICLR: 53.53 (+0.19), CVD: 100.45 (-0.42)
PAREXEL Expands Clinical Trial Supply And Logistics Services Through Opening Of New European Coordination Hub and Distribution Center
PR Newswire - Tue Nov 11, 5:00AM CST
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the opening of its new European Coordination Hub and Distribution Center in Berlin-Schonefeld, Germany. The facility expands the Company's capacity to provide comprehensive clinical trial supply and logistics services to support clients' local, regional and global trial requirements. These capabilities include synchronized coordination of clinical trial supplies, ancillary supplies and central laboratory services.
PRXL: 54.92 (+0.42)
Post Earnings Update: Parexel International Has Sunk 15.1% Lower in Past Week (PRXL)
Comtex SmarTrend(R) - Mon Nov 10, 12:17PM CST
12 days ago, on October 29th, 2014, Parexel International (NASDAQ
RXL) reported its earnings. Analysts, on average, expected earnings of $0.58 per share on sales of $499.4 million. Parexel International actually reported earnings of $0.65 per share on sales of $573.7 million, beating EPS estimates by $0.07 and beating revenue estimates by $74.3 million. Since the company's report, shares of Parexel International have fallen from $63.56 to $53.97, representing a loss of 15.1% in the past 12 days.
PRXL: 54.92 (+0.42)
PAREXEL International to Present at Jefferies Global Healthcare Conference
PR Newswire - Mon Nov 10, 8:30AM CST
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Jefferies Global Healthcare Conference in London. Ingo Bank, Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 1:00pm GMT on Thursday, November 20, 2014.
PRXL: 54.92 (+0.42)
Insider Trading Alert - PRXL, SCOR And HLF Traded By Insiders
at The Street - Fri Nov 07, 11:30AM CST
Stocks with insider trader activity include PRXL, SCOR and HLF
HLF: 37.48 (-0.66), PRXL: 54.92 (+0.42), SCOR: 43.23 (-0.04)
PAREXEL International Beats Q1 Earnings, Misses Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:48AM CST
PAREXEL International (PRXL) reported adjusted earnings per share of 65 cents in the first quarter of fiscal 2015, which beat both the Zacks Consensus Estimate of 58 cents and the year-ago earnings of 45 cents.
BGMD: 0.47 (+0.03), PRXL: 54.92 (+0.42), BEAT: 8.20 (unch), ICLR: 53.53 (+0.19)
PAREXEL International To Present At Credit Suisse Healthcare Conference
PR Newswire - Tue Nov 04, 8:50AM CST
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Credit Suisse Healthcare Conference in Phoenix, AZ. Ingo Bank, Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 1:00 p.m. MST on Tuesday, November 11, 2014.
PRXL: 54.92 (+0.42)
Quarterly Financial Results and Product Approval - Research Reports on Pacira, PAREXEL, WellPoint, Illumina and St. Jude Medical
PR Newswire - Tue Nov 04, 8:00AM CST
Today, Analysts Review released its research reports regarding Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), PAREXEL International Corporation (NASDAQ: PRXL), WellPoint Inc. (NYSE: WLP), Illumina, Inc. (NASDAQ: ILMN) and St. Jude Medical, Inc. (NYSE: STJ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7670-100free.
PRXL: 54.92 (+0.42), STJ: 65.54 (-0.16), ILMN: 188.08 (-0.19), PCRX: 87.24 (-0.59), WLP: 126.70 (+1.20)
Nasdaq stocks posting largest percentage decreases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
BBOX: 23.38 (+0.15), AFOP: 13.70 (unch), AMCC: 6.34 (+0.02), NSIT: 23.29 (+0.11), ARAY: 7.00 (+0.10), HTWR: 79.27 (+0.66), CCUR: 7.00 (-0.05), THRM: 41.32 (+0.55), RPXC: 13.97 (+0.02), BWEN: 6.56 (+0.01), PRXL: 54.92 (+0.42), AZPN: 38.02 (-0.01), BBSI: 23.07 (-1.21), CRUS: 19.55 (-0.14), ARCP: 8.65 (+0.15), PCRX: 87.24 (-0.59), XOOM: 15.02 (+0.36)
Parexel International Falls 16.38% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Oct 30, 3:47PM CDT
Parexel International (NASDAQ RXL) traded in a range yesterday that spanned from a low of $52.86 to a high of $55.77. Yesterday, the shares fell 16.4%, which took the trading range below the 3-day low of $62.48 on volume of 5.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
PRXL: 54.92 (+0.42)
PAREXEL International's (PRXL) CEO Josef H. von Rickenbach on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 2:40PM CDT
PRXL: 54.92 (+0.42)
Stocks Improve In Afternoon Trading; Taser Surges On Earnings
at Investor's Business Daily - Thu Oct 30, 12:25PM CDT
Stocks improved Thursday afternoon as the Nasdaq entered positive territory, but just barely. The Dow Jones industrial average continued to lead, with a 0.9% gain. Visa (V), which reported better-than-expected earnings Wednesday, was the Dow's bigger...
ABC: 87.87 (+0.16), PRXL: 54.92 (+0.42), BIDU: 248.49 (+0.91), V: 249.35 (-0.86), TASR: 19.59 (+0.66)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 11:47AM CDT
ABMD: 33.02 (+0.03), CALX: 11.37 (-0.01), LOJN: 2.72 (+0.03), ALU: 3.17 (unch), CDTI: 2.48 (-0.16), NKA: 4.63 (-0.20), ARAY: 7.00 (+0.10), GLUU: 3.84 (+0.05), PDII: 1.78 (+0.03), OMER: 19.00 (+1.51), ESBF: 18.85 (+0.02), CRNT: 1.11 (-0.03), CBDE: 0.95 (+0.02), PRXL: 54.92 (+0.42), BWEN: 6.56 (+0.01), ALDX: 7.77 (-0.14), BBSI: 23.07 (-1.21), LAKE: 12.75 (-0.23), OPHC: 0.94 (+0.02), WTW: 25.90 (+0.28)
PAREXEL International (PRXL) Stock Lower After Weak Fiscal 2015 First Quarter Revenue Results
at The Street - Thu Oct 30, 10:37AM CDT
Shares of PAREXEL (PRXL) are down after reporting lower 2015 first quarter fiscal year revenue results that missed analysts' estimates.
PRXL: 54.92 (+0.42)
Stocks Turn Mixed As Dow Rises; Gentherm Tumbles As F5 Rises
at Investor's Business Daily - Thu Oct 30, 9:35AM CDT
Stocks opened lower, but quickly turned mixed Thursday with some support from a better-than-expected third-quarter GDP estimate. The Dow Jones industrial average shed early losses to trade up 0.4%. The Nasdaq slumped 0.5%. The S&P 500 split the...
PRXL: 54.92 (+0.42), CHRW: 71.70 (-0.47), FFIV: 126.43 (-0.16), THRM: 41.32 (+0.55)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 8:18AM CDT
KNDI: 15.57 (+0.71), ALU: 3.17 (unch), CDTI: 2.48 (-0.16), VSR: 3.08 (+0.05), NBG: 2.18 (-0.05), ARAY: 7.00 (+0.10), GLUU: 3.84 (+0.05), OCLS: 1.80 (+0.01), CEMI: 4.34 (+0.19), TTWO: 26.11 (+0.01), PRXL: 54.92 (+0.42), RDN: 16.68 (+0.20), BBD: 14.29 (+0.11), NVAX: 5.30 (+0.09), APT: 3.06 (-0.05), BBSI: 23.07 (-1.21), LAKE: 12.75 (-0.23), GOL: 5.12 (+0.31), TASR: 19.59 (+0.66), AUY: 3.90 (+0.24), PCRX: 87.24 (-0.59), ITUB: 14.09 (-0.02)
Stock Futures Lower, Techs Weak; Visa And Grand Canyon Rising
at Investor's Business Daily - Thu Oct 30, 8:10AM CDT
Stock futures veered lower ahead of Thursday's open, with tech stocks and small caps under stress. Dow and S&P 500 futures traded with comparatively mild losses, 28.3 and 11.1 points, respectively, below fair market value. Nasdaq 100 futures slumped...
LOPE: 47.99 (+0.34), PRXL: 54.92 (+0.42), NVO: 44.28 (+0.98), V: 249.35 (-0.86), BIDU: 248.49 (+0.91), APT: 3.06 (-0.05), LAKE: 12.75 (-0.23), JDSU: 13.43 (-0.20)
Downgrade Alert for Parexel International (PRXL)
Comtex SmarTrend(R) - Thu Oct 30, 7:06AM CDT
Parexel International (NASDAQ RXL) was downgraded from Outperform to Neutral at RW Baird today. The stock closed yesterday at $63.56 on volume of 775,000 shares, above average daily volume of 630,000. In the past 52 weeks, shares of Parexel International have traded between a low of $37.53 and a high of $64.72 and closed yesterday at $63.56, which is 69% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has risen 0.5%.
PRXL: 54.92 (+0.42)
PAREXEL declines in AH trade on Q1 earnings and lowered guidance
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 6:42PM CDT
PRXL: 54.92 (+0.42)
Recent News posted below.
Parexel International Corp PRXL other info.
http://investorshangout.com/Parexel-Internati...RXL-55174/
PRXL Parexel International Corp Recent Headline News
Regulatory Affairs Outsourcing Market - Global Industry Analysis 2014 - 2020
M2 - Tue Nov 11, 9:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/8t6h79/regulatory) has announced the addition of the "Regulatory Affairs Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering. The global regulatory affairs outsourcing market is segmented by services into regulatory affairs; clinical trial applications and product registrations; regulatory writing and publishing; regulatory consulting and legal representation; and others (post approval maintenance, reimbursement consulting etc.). Regulatory writing and publishing services accounted for the largest share of more than 40% of the overall regulatory affairs outsourcing market in 2013 and is expected to maintain its lead during the forecast period through 2014 to 2020. Factors that have contributed towards the large market size of the regulatory writing and publishing services are increasing need for user/reviewer friendly and complete drug application submissions, and sound knowledge for drug development services. Additionally, a well-written clinical study report (CSR) can help in adding a lot of value in the final production of clinical trial documentation, thereby complying with stringent regulatory requirements of the drug development process. The regulatory consulting and legal representation services segment is also estimated to grow at an approximate CAGR of above 14%. The major driving factors for the rapid growth of this segment are growing demand of drug manufacturing companies for product safety and efficacy evaluations. Furthermore, the need of various pharmaceutical companies to minimize business impacts such as product recalls and loss of sales, and ensure global environmental compliance would also propel the growth of the regulatory consulting and legal representation services segment. Currently, the regulatory affairs outsourcing market is fragmented due to the involvement of several established and emerging contract research organizations. Some of the major players operating in the global regulatory affairs outsourcing market are Charles River Laboratories International, Inc., Covance Group Ltd., Parexel International Corporation, WuXi AppTec, Quintiles Transnational Holdings, Inc., Medpace, Inc., Promedica International, Clinilabs, Inc., Accell Clinical Research, LLC, Criterium, Inc., ICON plc and Pharmaceutical Product Development. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Regulatory Affairs Outsourcing Market Overview Chapter 4 Global Regulatory Affairs Outsourcing Market, by Services Chapter 5 Global Regulatory Affairs Outsourcing Market, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - Accell Clinical Research, LLC - Charles River Laboratories International, Inc. - Clinilabs, Inc. - Covance, Inc. - Criterium, Inc. - ICON plc - Medpace, Inc. - PAREXEL International Corporation - PRA International, Inc. - Pharmaceutical Product Development, LLC - Promedica International - Quintiles Transnational Corporation - WuXi AppTec For more information visit http://www.researchandmarkets.com/research/8t6h79/regulatory
PRXL: 54.92 (+0.42), CRL: 64.16 (+0.23), ICLR: 53.53 (+0.19), CVD: 100.45 (-0.42)
PAREXEL Expands Clinical Trial Supply And Logistics Services Through Opening Of New European Coordination Hub and Distribution Center
PR Newswire - Tue Nov 11, 5:00AM CST
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the opening of its new European Coordination Hub and Distribution Center in Berlin-Schonefeld, Germany. The facility expands the Company's capacity to provide comprehensive clinical trial supply and logistics services to support clients' local, regional and global trial requirements. These capabilities include synchronized coordination of clinical trial supplies, ancillary supplies and central laboratory services.
PRXL: 54.92 (+0.42)
Post Earnings Update: Parexel International Has Sunk 15.1% Lower in Past Week (PRXL)
Comtex SmarTrend(R) - Mon Nov 10, 12:17PM CST
12 days ago, on October 29th, 2014, Parexel International (NASDAQ
RXL) reported its earnings. Analysts, on average, expected earnings of $0.58 per share on sales of $499.4 million. Parexel International actually reported earnings of $0.65 per share on sales of $573.7 million, beating EPS estimates by $0.07 and beating revenue estimates by $74.3 million. Since the company's report, shares of Parexel International have fallen from $63.56 to $53.97, representing a loss of 15.1% in the past 12 days. PRXL: 54.92 (+0.42)
PAREXEL International to Present at Jefferies Global Healthcare Conference
PR Newswire - Mon Nov 10, 8:30AM CST
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Jefferies Global Healthcare Conference in London. Ingo Bank, Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 1:00pm GMT on Thursday, November 20, 2014.
PRXL: 54.92 (+0.42)
Insider Trading Alert - PRXL, SCOR And HLF Traded By Insiders
at The Street - Fri Nov 07, 11:30AM CST
Stocks with insider trader activity include PRXL, SCOR and HLF
HLF: 37.48 (-0.66), PRXL: 54.92 (+0.42), SCOR: 43.23 (-0.04)
PAREXEL International Beats Q1 Earnings, Misses Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:48AM CST
PAREXEL International (PRXL) reported adjusted earnings per share of 65 cents in the first quarter of fiscal 2015, which beat both the Zacks Consensus Estimate of 58 cents and the year-ago earnings of 45 cents.
BGMD: 0.47 (+0.03), PRXL: 54.92 (+0.42), BEAT: 8.20 (unch), ICLR: 53.53 (+0.19)
PAREXEL International To Present At Credit Suisse Healthcare Conference
PR Newswire - Tue Nov 04, 8:50AM CST
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Credit Suisse Healthcare Conference in Phoenix, AZ. Ingo Bank, Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 1:00 p.m. MST on Tuesday, November 11, 2014.
PRXL: 54.92 (+0.42)
Quarterly Financial Results and Product Approval - Research Reports on Pacira, PAREXEL, WellPoint, Illumina and St. Jude Medical
PR Newswire - Tue Nov 04, 8:00AM CST
Today, Analysts Review released its research reports regarding Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), PAREXEL International Corporation (NASDAQ: PRXL), WellPoint Inc. (NYSE: WLP), Illumina, Inc. (NASDAQ: ILMN) and St. Jude Medical, Inc. (NYSE: STJ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7670-100free.
PRXL: 54.92 (+0.42), STJ: 65.54 (-0.16), ILMN: 188.08 (-0.19), PCRX: 87.24 (-0.59), WLP: 126.70 (+1.20)
Nasdaq stocks posting largest percentage decreases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
BBOX: 23.38 (+0.15), AFOP: 13.70 (unch), AMCC: 6.34 (+0.02), NSIT: 23.29 (+0.11), ARAY: 7.00 (+0.10), HTWR: 79.27 (+0.66), CCUR: 7.00 (-0.05), THRM: 41.32 (+0.55), RPXC: 13.97 (+0.02), BWEN: 6.56 (+0.01), PRXL: 54.92 (+0.42), AZPN: 38.02 (-0.01), BBSI: 23.07 (-1.21), CRUS: 19.55 (-0.14), ARCP: 8.65 (+0.15), PCRX: 87.24 (-0.59), XOOM: 15.02 (+0.36)
Parexel International Falls 16.38% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Oct 30, 3:47PM CDT
Parexel International (NASDAQ
RXL) traded in a range yesterday that spanned from a low of $52.86 to a high of $55.77. Yesterday, the shares fell 16.4%, which took the trading range below the 3-day low of $62.48 on volume of 5.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. PRXL: 54.92 (+0.42)
PAREXEL International's (PRXL) CEO Josef H. von Rickenbach on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 2:40PM CDT
PRXL: 54.92 (+0.42)
Stocks Improve In Afternoon Trading; Taser Surges On Earnings
at Investor's Business Daily - Thu Oct 30, 12:25PM CDT
Stocks improved Thursday afternoon as the Nasdaq entered positive territory, but just barely. The Dow Jones industrial average continued to lead, with a 0.9% gain. Visa (V), which reported better-than-expected earnings Wednesday, was the Dow's bigger...
ABC: 87.87 (+0.16), PRXL: 54.92 (+0.42), BIDU: 248.49 (+0.91), V: 249.35 (-0.86), TASR: 19.59 (+0.66)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 11:47AM CDT
ABMD: 33.02 (+0.03), CALX: 11.37 (-0.01), LOJN: 2.72 (+0.03), ALU: 3.17 (unch), CDTI: 2.48 (-0.16), NKA: 4.63 (-0.20), ARAY: 7.00 (+0.10), GLUU: 3.84 (+0.05), PDII: 1.78 (+0.03), OMER: 19.00 (+1.51), ESBF: 18.85 (+0.02), CRNT: 1.11 (-0.03), CBDE: 0.95 (+0.02), PRXL: 54.92 (+0.42), BWEN: 6.56 (+0.01), ALDX: 7.77 (-0.14), BBSI: 23.07 (-1.21), LAKE: 12.75 (-0.23), OPHC: 0.94 (+0.02), WTW: 25.90 (+0.28)
PAREXEL International (PRXL) Stock Lower After Weak Fiscal 2015 First Quarter Revenue Results
at The Street - Thu Oct 30, 10:37AM CDT
Shares of PAREXEL (PRXL) are down after reporting lower 2015 first quarter fiscal year revenue results that missed analysts' estimates.
PRXL: 54.92 (+0.42)
Stocks Turn Mixed As Dow Rises; Gentherm Tumbles As F5 Rises
at Investor's Business Daily - Thu Oct 30, 9:35AM CDT
Stocks opened lower, but quickly turned mixed Thursday with some support from a better-than-expected third-quarter GDP estimate. The Dow Jones industrial average shed early losses to trade up 0.4%. The Nasdaq slumped 0.5%. The S&P 500 split the...
PRXL: 54.92 (+0.42), CHRW: 71.70 (-0.47), FFIV: 126.43 (-0.16), THRM: 41.32 (+0.55)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 8:18AM CDT
KNDI: 15.57 (+0.71), ALU: 3.17 (unch), CDTI: 2.48 (-0.16), VSR: 3.08 (+0.05), NBG: 2.18 (-0.05), ARAY: 7.00 (+0.10), GLUU: 3.84 (+0.05), OCLS: 1.80 (+0.01), CEMI: 4.34 (+0.19), TTWO: 26.11 (+0.01), PRXL: 54.92 (+0.42), RDN: 16.68 (+0.20), BBD: 14.29 (+0.11), NVAX: 5.30 (+0.09), APT: 3.06 (-0.05), BBSI: 23.07 (-1.21), LAKE: 12.75 (-0.23), GOL: 5.12 (+0.31), TASR: 19.59 (+0.66), AUY: 3.90 (+0.24), PCRX: 87.24 (-0.59), ITUB: 14.09 (-0.02)
Stock Futures Lower, Techs Weak; Visa And Grand Canyon Rising
at Investor's Business Daily - Thu Oct 30, 8:10AM CDT
Stock futures veered lower ahead of Thursday's open, with tech stocks and small caps under stress. Dow and S&P 500 futures traded with comparatively mild losses, 28.3 and 11.1 points, respectively, below fair market value. Nasdaq 100 futures slumped...
LOPE: 47.99 (+0.34), PRXL: 54.92 (+0.42), NVO: 44.28 (+0.98), V: 249.35 (-0.86), BIDU: 248.49 (+0.91), APT: 3.06 (-0.05), LAKE: 12.75 (-0.23), JDSU: 13.43 (-0.20)
Downgrade Alert for Parexel International (PRXL)
Comtex SmarTrend(R) - Thu Oct 30, 7:06AM CDT
Parexel International (NASDAQ
RXL) was downgraded from Outperform to Neutral at RW Baird today. The stock closed yesterday at $63.56 on volume of 775,000 shares, above average daily volume of 630,000. In the past 52 weeks, shares of Parexel International have traded between a low of $37.53 and a high of $64.72 and closed yesterday at $63.56, which is 69% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has risen 0.5%. PRXL: 54.92 (+0.42)
PAREXEL declines in AH trade on Q1 earnings and lowered guidance
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 6:42PM CDT
PRXL: 54.92 (+0.42)
